Product

产品服务

产品服务
首页 产品服务 原料药

Active Pharmaceutical Ingredient

原料药

商业化项目 (Commercial API)

No.

API Product

CAS No

DMF/CEP

Standard

Indication

1

Benazepril HCl

盐酸贝那普利

86541-74-4

NMPA DMF: Y20190002852

DMF: 033744

CEP:2015-322

CDSCO

RC/BD-002644

USP/EP/Ch.P.

Cardiovascular

2

Tirofiban HCl

盐酸替罗非班

150915-40-5

NMPA DMF: Y20190006974

DMF: 032701

EU/ASMF/00701

In-house

Cardiovascular

3

Dronedarone HCl

盐酸决奈达隆

141625-93-6

NMPA DMF:Y20220000297

DMF: 037247

CEP: 2022-277

USP/EP/Ch.P.

Cardiovascular

4

Eribulin Mesylate

甲磺酸艾立布林

441045-17-6

DMF:035523

EU/ASMF/00569

JP

Anti-Cancer

5

Ibrutinib(Form A&C)

伊布替尼

936563-96-1

NMPA DMF: Y20230000804

DMF:038919

DMF:031917

In-house

Anti-Cancer

6

Alogliptin Benzoate

苯甲酸阿格列汀

850649-62-6

NMPA DMF: Y20230001355

DMF:039984

In-house

Diabetes

7

Fosaprepitant Dimeglumine

福沙匹坦双葡甲胺

265121-04-8

NMPA DMF: Y20200001493

DMF:035766

JP MF:304MF10040

In-house

Anti-Cancer

8

Aprepitant

阿瑞匹坦

170729-80-3

NMPA DMF: Y20200000221

DMF:033175

CEP:2019-117

JP MF:230MF10074

USP/EP

Anti-Cancer

9

Dapagliflozin

达格列净

960404-48-2

NMPA DMF: Y20220000848

In-house

Diabetes

10

Entecavir

恩替卡韦

209216-23-9

NMPA DMF: Y20170000425

DMF:033104

CEP:2018-006

EP/USP

Anti-Virus

11

Gefitinib

吉非替尼

184475-35-2

NMPA DMF: Y20200001369

CEP: 2022-291

EP

Anti-Cancer

12

Linagliptin

利格列汀

668270-12-0

DMF:031294

In-house

Diabetes

13

Fasudil HCl

盐酸法舒地尔

105628-07-7

NMPA DMF: Y20220000495

JP MF:231MF10048

Ch.P./JP

Cardiovascular

14

Flurbiprofen Axetil

氟比洛芬酯

91503-79-6

NMPA DMF: Y20220000095

In-house

Analgesic

多肽API (Polypeptide API)

No.

API Product

CAS No

DMF/CEP

Standard

Indication

15

Difelikefalin Acetate

醋酸地非法林

1024829-44-4

Validated

In-house

Antipruritic

16

Linaclotide

利那洛肽

851199-59-2

In progress

In-house

IBS-C

17

Tirzepatide

替尔泊肽

2023788-19-2

In progress

In-house

Diabetes

18

Etelcalcetide HCl

盐酸依特卡肽

1334237-71-6

In progress

In-house

SHPT

19

Semaglutide

司美格鲁肽

910463-68-2

In progress

In-house

Diabetes

重点在研项目 (R&D API)

No.

API Product

CAS No

DMF/CEP

Standard

Indication

20

Trabectedin

曲贝替定

114899-77-3

In progress

In-house

Anti-Cancer

21

Lurbinectedin

芦比替定

497871-47-3

DMF:037624

In-house

Anti-Cancer

22

Baricitinib

巴瑞替尼

1187594-09-7

DMF:036732

In-house

Rheumatoid Arthritis

23

Carfilzomib

卡非佐米

868540-17-4

In progress

In-house

Anti-Cancer

24

Pralsetinib

普拉替尼

2097132-94-8

In progress

In-house

Anti-Cancer

25

Exatecan Mesylate

甲磺酸依喜替康

169869-90-3

In progress

In-house

Anti-Cancer

26

Landiolol HCl

盐酸兰地洛尔

144481-98-1

In progress

In-house

Cardiovascular

27

Pentoxifylline

己酮可可碱

6493-05-6

In progress

In-house

Cardiovascular

28

Ozanimod HCl

盐酸奥扎莫德

1618636-37-5

In progress

In-house

Multiple Sclerosis

29

Enoxaparin Sodium

依诺肝素钠

679809-58-6

In progress

In-house

Cardiovascular

30

Dalteparin Sodium

达肝素钠

9041-08-1

In progress

In-house

Cardiovascular

31

Nadroparin Calcium

那屈肝素钙

37270-89-6

In progress

In-house

Cardiovascular

32

Parnaparin Sodium

帕肝素钠

9041-08-1

In progress

In-house

Cardiovascular

33

Reviparin sodium

瑞肝素钠

9005-49-6

In progress

In-house

Cardiovascular

34

Bemiparin Sodium

贝米肝素钠

9041-08-1

In progress

In-house

Cardiovascular

35

Fondaparinux Sodium

磺达肝癸钠

114870-03-0

DMF:037499

In-house

Cardiovascular

  • APIs and intermediates covered by valid patents protection in the specific market shall only be used for the purpose of seeking regulatory approval and shall not be used to treat humans and animals for commercial purposes.
  • The advanced intermediates of all above APIs are available, with DMF support if required.

Related equipment

相关设备

不锈钢反应釜1
不锈钢反应釜1
不锈钢反应釜2
不锈钢反应釜2
离心机1
离心机1
离心机2
离心机2
双锥回转真空干燥机
双锥回转真空干燥机
气流粉碎机
气流粉碎机
固体投料器
固体投料器
一般生产区1
一般生产区1
一般生产区2
一般生产区2